Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2017 Aug 10;59(4):888–895. doi: 10.1080/10428194.2017.1361032

Table 2.

Characteristics and performance metrics of radiology studies available at study sites for patients during first remission, stratified by image type and indication.

Surveillance imaging only, all types Surveillance imaging, CT Surveillance imaging, PET/CT Surveillance imaging, MRI
N = 801 N = 587 N = 205 N = 9
Radiologist diagnosis of study
 No concerning findings 726 (91%) 534 (91%) 184 (90%) 8 (89%)
 Concerning or positive for relapse 68 (8%) 49 (8%) 18 (9%) 1 (11%)
 Non-diagnostic 5 (1%) 2 (<1%) 3 (1%) 0 (0%)
 Other 2 (<1%) 1 (<1%) 0 (0%) 0 (0%)
Total true positive studies 29 (4%) 24 (4%) 4 (2%) 1 (11%)
Positive predictive value 43% 49% 22% 100%

CT: computerized tomography; PET/CT: positron emission tomography with computerized tomography overlay.